| MicroRNA-125b exerts tumor-suppressive effects in hepatic carcinogenesis through the suppression of oncogene LIN28B expression. | liver, |
| miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-alpha, CCNJ, and MEGF9. | breast, |
| miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in primary gastric cancer. | gastric, |
| miR-125b-5p functions as a tumor suppressor and regulates breast cancer cell progression through targeting KIAA1522 | breast, |
| This study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. | None |
| a novel molecular mechanism by which MMP13 is up-regulated in cSCCs and indicate that miR-125b plays a tumor suppressive role in cSCC. | None |
| The tumor-suppressive miR-125b served as a negative regulator of SUV39H1[microRNA 125b] | None |
| MiR-125b may have an oncogenic role in glioblastoma cells by promoting cell proliferation and inhibiting apoptosis. | glioblastoma, |